NFKB1 and carcinoma: We conclude that AEG-1/MTDH and NF-κB signaling is active in epithelial ovarian cancer, where there appears to be a gradual increase in the expression of these molecules when moving across the spectrum of ovarian carcinogenesis, from borderline ovarian tumours to the frank malignant epithelial carcinomas.